Two of our speakers, IBM’s Prasad Kodali (left) and Weill Cornell Medical College’s Lewis Cantley, chat before the festivities get underway.
photos by Keith Spiro Photography
Attendees begin filing in before the show.
photos by Keith Spiro Photography
That’s not just water, it’s…OK, no it’s just water.
photos by Keith Spiro Photography
Not an empty seat in the house. The crowd has continued to grow for our New York biotech events, a testament to the momentum building in the city.
photos by Keith Spiro Photography
To give you a sense of the growth in New York biotech, behind these attendees is the Alexandria Center’s latest tower, mid-construction. It didn’t exist a few years ago.
photos by Keith Spiro Photography
Speaking of the Alexandria Center, here’s Alexandria Real Estate Equities CEO Joel Marcus giving an overview of the city’s life science efforts. The spot we were all sitting in was a “contaminated laundry site” not too long ago, he said.
photos by Keith Spiro Photography
Seattle’s Accelerator Corp. has started up two companies, Petra Pharma and Lodo Therapeutics, since opening up a branch in New York. David Schubert, Accelerator’s chief operating officer, gives a behind-the-scenes look at how those two companies came together with the help of scientific founders Lewis Cantley (left, Petra) and Sean Brady (right, Lodo).
photos by Keith Spiro Photography
Attendee pro tip: Arrive early, or it’s standing room only.
photos by Keith Spiro Photography
Flagship Ventures partner Doug Cole told the audience what led his firm to help manage a $150 million biotech fund for New York City---and what locals must do to maximize the “raw potential” in New York’s biotech scene.
photos by Keith Spiro Photography
Among the attendees looking on is Jason Park (front right), a principal at Flagship and the point man for the firm’s biotech efforts in New York.
photos by Keith Spiro Photography
We always try to give folks a chance to chime in and ask questions.
photos by Keith Spiro Photography
Columbia University professor and Kallyope co-founder Charles Zuker talks about how the circuitry of the gut-brain axis---an information superhighway between the cells in our guts and brain---is implicated in our senses of what tastes sweet or bitter.
photos by Keith Spiro Photography
With much of the crowd making their way out to go schmooze, Kallyope CEO and ex-Merck executive Nancy Thornberry sticks around to talk to an attendee.
photos by Keith Spiro Photography
The post-event networking was a zoo. Attendees stayed late to keep the party going.
photos by Keith Spiro Photography
And the drinks were flowing, which never hurts.
photos by Keith Spiro Photography
One of the locals to show up was Organovo and Modern Meadow co-founder Andras Forgacs. Modern Meadow is based in the Brooklyn Army Terminal’s “BioBAT” space.
photos by Keith Spiro Photography
The vibe at the event was great. You do get the sense that this is a group passionate about changing things in New York.
photos by Keith Spiro Photography
Good times, handshakes, and business card exchanges.
photos by Keith Spiro Photography
Last week, we held our yearly Big Apple biotech event, “New York’s Life Science Disruptors,” which provides an inside look at the people and companies that are shaping the emerging life sciences scene in the city. As per usual, today I’m circling back with the photos.
Just wanted to say thanks again to all the folks who came out, as well as to our speakers, sponsors, and event host Alexandria Real Estate Equities. (And a hat tip to Keith Spiro of Keith Spiro Photography for the photos.) Hope to see you all again next year.
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
BiocomSponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins DiscoverySponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.